Evolution of cell culture systems for HCV

Antiviral Therapy

Volumn 18, Issue 3 PARTB, 2013, Pages 523-530

  Taylor, Deborah R ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC G 418; BOCEPREVIR; RIBAVIRIN; TELAPREVIR; VIRUS PROTEIN;

ANTIVIRAL RESISTANCE; CELL CULTURE; CULTURE MEDIUM; CYTOKINE RELEASE; GENETIC ORGANIZATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; REPLICON; REVIEW; RNA REPLICATION; VIROGENESIS; VIRUS ATTACHMENT; VIRUS CULTURE; VIRUS DETECTION; VIRUS ENTRY; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TITRATION;

ANTIVIRAL AGENTS; CELL CULTURE TECHNIQUES; DRUG THERAPY, COMBINATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; OLIGOPEPTIDES; POLYETHYLENE GLYCOLS; PROLINE; RECOMBINANT PROTEINS; REPLICON; RIBAVIRIN; RNA, VIRAL; VIRUS CULTIVATION; VIRUS REPLICATION;

EID: 84879678839     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2593     Document Type: Review

References (53)

1. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000; 242:55-84.
2. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282:938-941.
3. Flint M, Loomis-Price LD, Shotton C, et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 1999; 73:6235-6244.
4. Cormier EG, Tsamis F, Kajumo F, et al. CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci U S A 2004; 101:7270-7274.
5. Maillard P, Huby T, Andreo U, et al. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J 2006; 20:735-737.
6. Scarselli E, Cerino R, Roccasecca RM, et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002; 21:5017-5025.
7. Evans MJ, von Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007; 446:801-805.
8. Agnello V, Abel G, Elfahal M, et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 1999; 96:12766-12771.
9. Monazahian M, Bohme I, Bonk S, et al. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol 1999; 57:223-229.
10. Pöhlmann S, Zhang J, Baribaud F, et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003; 77:4070-4080.
11. Cormier EG, Durso RJ, Tsamis F, et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 2004; 101:14067-14072.
12. Lozach PY, Amara A, Bartosch B, et al. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004; 279:32035-32045.
13. Mee CJ, Grove J, Harris HJ, Hu K, Balfe P, McKeating JA. Effect of cell polarization on hepatitis C virus entry. J Virol 2008; 82:461-470.
14. Ploss A, Evans MJ, Gaysinskaya VA, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 2009; 457:882-886.
15. Tellinghuisen TL, Evans MJ, von Hahn T, et al. Studying hepatitis C virus: making the best of a bad virus. J Virol 2007; 81:8853-8867.
16. Dorner M, Horwitz JA, Robbins J, et al. A genetically humanized mouse model for hepatitis C virus infection. Nature 2011; 474:208-211.
17. Pestova T V, Shatsky IN, Fletcher SP, et al. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev 1998; 12:67.
18. Bartenschlager R. Hepatitis C virus replicons: potential role for drug development. Nat Rev Drug Discov 2002; 1:911-916.
19. Iacovacci S, Manzin A, Barca S, et al. Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology 1997; 26:1328.
20. Rumin S, Berthillon P, Tanaka E, et al. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 1999; 80:3007-3018.
21. Nakajima N, Hijikata M, Yoshikura H, et al. Characterization of long-term cultures of hepatitis C virus. J Virol 1996; 70:3325-3329.
22. Deriabin PG, Viazov SO, Isaeva EI, et al. [Persistence of hepatitis C virus in newborn mice brain cell culture]. Vopr Virusol 1997; 42:254-258. Russian.
23. Lohmann V, Koch J-O, Herian U, et al. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285:110-113.
24. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000; 290:1972-1974.
25. Krieger N, Lohman V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptative mutations. J Virol 2001; 75:4614-4624.
26. Lohmann V, Korner F, Dobierzewska A, Bartenschlager R. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 2001; 75:1437-1449.
27. Abe K, Ikeda M, Dansako H, et al. Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA. Virus Res 2007; 125:88-97.
28. Yi M, Ma Y, Yates J, Lemon SM. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 2007; 81:629-638.
29. Kohashi T, Maekawa S, Sakamoto N, et al. Site-specific mutation of the interferon sensitivity-determining region (ISDR) modulates hepatitis C virus replication. J Viral Hepat 2006; 13:582-590.
30. Liu S, Ansari IH, Das SC, Pattnaik AK. Insertion and deletion analyses identify regions of non-structural protein 5A of hepatitis C virus that are dispensable for viral genome replication. J Gen Virol 2006; 87:323-327.
31. Evans MJ, Rice CM, Goff SP. Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A 2004; 101:13038-13043.
32. Ikeda M, MinKyung Y, Kui L, Lemon SM. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J Virol 2002; 76:2997-3006.
33. Zhu Q, Guo JT, Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 2003; 77:9204-9210.
34. Blight KJ, McKeating JA, Marcotrigiano J, Rice CM. Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture. J Virol 2003; 77:3181-3190.
35. Kato T, Date T, Miyamoto M, et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003; 125:1808-1817.
36. Kato T, Furusaka A, Miyamoto M, et al. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J Med Virol 2001; 64:334-339.
37. Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 2002; 76:13001-13014.
38. Sumpter R Jr, Loo Y, Foy E, et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 2005; 79:2689-2699.
39. Koutsoudakis G, Herrmann E, Kallis S, et al. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 2007; 81:588-598.
40. Date T, Kato T, Miyamoto M, et al. Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells. J Biol Chem 2004; 279:22371-22376.
41. Zhu Q, Guo JT, Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 2003; 77:9204-9210.
42. Bukh J, Pietschmann T, Lohman V, et al. Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 2002; 99:14416-14421.
43. Hsu M, Zhang J, Flint M, et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 2003; 100:7271-7276.
44. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003; 197:633-642.
45. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791-796.
46. Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 2005; 102:9294-9299.
47. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623-626.
48. Lindenbach BD, Ploss A, Vanwolleghem T, et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A 2006; 103:3805-3809.
49. Gottwein JM, Scheel TK, Hoegh AM, et al. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 2007; 133:1614-1626.
50. Pietschmann T, Kaul A, Koutsoudakis G, et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 2006; 103:7408-7413.
51. Scheel TK, Gottwein JM, Jensen TB, et al. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc Natl Acad Sci U S A 2008; 105:997-1002.
52. Taylor DR, Puig M, Darnell MR, Mihalik K, Feinstone SM. New antiviral pathway that mediates HCV replicon interferon sensitivity through ADAR1. J Virol 2005; 79:6291-6298.
53. Silberstein E, Mihalik K, Ulitzky L, et al. Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture. PLoS Pathog 2010; 6:e1000910.